These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22606234)

  • 1. Augmented cardiac hypertrophy in response to pressure overload in mice lacking ELTD1.
    Xiao J; Jiang H; Zhang R; Fan G; Zhang Y; Jiang D; Li H
    PLoS One; 2012; 7(5):e35779. PubMed ID: 22606234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maslinic acid protects against pressure overload-induced cardiac hypertrophy in mice.
    Liu YL; Kong CY; Song P; Zhou H; Zhao XS; Tang QZ
    J Pharmacol Sci; 2018 Oct; 138(2):116-122. PubMed ID: 30389277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activating transcription factor 3 deficiency promotes cardiac hypertrophy, dysfunction, and fibrosis induced by pressure overload.
    Zhou H; Shen DF; Bian ZY; Zong J; Deng W; Zhang Y; Guo YY; Li H; Tang QZ
    PLoS One; 2011; 6(10):e26744. PubMed ID: 22053207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.
    Xu X; Fassett J; Hu X; Zhu G; Lu Z; Li Y; Schnermann J; Bache RJ; Chen Y
    Hypertension; 2008 Jun; 51(6):1557-64. PubMed ID: 18391093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syndecan-4 deficiency accelerates the transition from compensated hypertrophy to heart failure following pressure overload.
    Li G; Xie J; Chen J; Li R; Wu H; Zhang X; Chen Q; Gu R; Xu B
    Cardiovasc Pathol; 2017; 28():74-79. PubMed ID: 28395201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IKKi deficiency promotes pressure overload-induced cardiac hypertrophy and fibrosis.
    Dai J; Shen DF; Bian ZY; Zhou H; Gan HW; Zong J; Deng W; Yuan Y; Li F; Wu QQ; Gao L; Zhang R; Ma ZG; Li HL; Tang QZ
    PLoS One; 2013; 8(1):e53412. PubMed ID: 23349709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis Following Pressure Overload by Suppressing Akt/mTOR Signaling.
    Gogiraju R; Hubert A; Fahrer J; Straub BK; Brandt M; Wenzel P; Münzel T; Konstantinides S; Hasenfuss G; Schäfer K
    Circ Heart Fail; 2019 Jan; 12(1):e005622. PubMed ID: 30621510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin modulates myocardial hypertrophy in response to chronic pressure overload in mice.
    Xie Z; Singh M; Singh K
    Hypertension; 2004 Dec; 44(6):826-31. PubMed ID: 15534078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Puerarin attenuates pressure overload-induced cardiac hypertrophy.
    Yuan Y; Zong J; Zhou H; Bian ZY; Deng W; Dai J; Gan HW; Yang Z; Li H; Tang QZ
    J Cardiol; 2014 Jan; 63(1):73-81. PubMed ID: 23906530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice.
    Wu L; Cao Z; Ji L; Mei L; Jin Q; Zeng J; Lin J; Chu M; Li L; Yang X
    Biochem Biophys Res Commun; 2017 Feb; 483(2):810-815. PubMed ID: 28013046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
    Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
    Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arctiin protects against cardiac hypertrophy through inhibiting MAPKs and AKT signaling pathways.
    Li J; Yuan YP; Xu SC; Zhang N; Xu CR; Wan CX; Ren J; Zeng XF; Tang QZ
    J Pharmacol Sci; 2017 Nov; 135(3):97-104. PubMed ID: 29108833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell antigen 1 protects against cardiac hypertrophy and fibrosis after pressure overload.
    Zhou H; Bian ZY; Zong J; Deng W; Yan L; Shen DF; Guo H; Dai J; Yuan Y; Zhang R; Lin YF; Hu X; Li H; Tang QZ
    Hypertension; 2012 Sep; 60(3):802-9. PubMed ID: 22851736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart.
    Hilfiker-Kleiner D; Hilfiker A; Kaminski K; Schaefer A; Park JK; Michel K; Quint A; Yaniv M; Weitzman JB; Drexler H
    Circulation; 2005 Sep; 112(10):1470-7. PubMed ID: 16129800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload.
    Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon.
    Klein G; Schaefer A; Hilfiker-Kleiner D; Oppermann D; Shukla P; Quint A; Podewski E; Hilfiker A; Schröder F; Leitges M; Drexler H
    Circ Res; 2005 Apr; 96(7):748-55. PubMed ID: 15761199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth Arrest-Specific 6 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy.
    Zhao YF; Xu DC; Zhu GF; Zhu MY; Tang K; Li WM; Xu YW
    Hypertension; 2016 Jan; 67(1):118-29. PubMed ID: 26573712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte-restricted inhibition of G protein-coupled receptor kinase-3 attenuates cardiac dysfunction after chronic pressure overload.
    von Lueder TG; Gravning J; How OJ; Vinge LE; Ahmed MS; Krobert KA; Levy FO; Larsen TS; Smiseth OA; Aasum E; Attramadal H
    Am J Physiol Heart Circ Physiol; 2012 Jul; 303(1):H66-74. PubMed ID: 22542621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.